Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
253 Leser
Artikel bewerten:
(1)

Med-X, Inc.: Med-X Appoints Linker & Associates as Sales Representative to Spearhead Business Development for Thermal-Aid Division

Leading Consumer Products Broker to Target Tier-1 Healthcare Distributors and Pharmacies to Enhance Thermal-Aid's National Distribution Footprint

LOS ANGELES, CA / ACCESSWIRE / September 6, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that it has appointed Linker & Associates, a leading consumer products broker, as a sales representative for the Company's fast-growing Thermal-Aid division.

Linker & Associates, led by President Brian Linker, brings over 20 years of consumer products broker experience working with several successful brands within the healthcare distribution space. Per the terms of the agreement, Linker & Associates will seek out prospective wholesale purchasers to enhance the national distribution footprint of Med-X's Thermal-Aid division, particularly within the healthcare and pharmacy space.

Med-X's popular Thermal-Aid line of pain management solutions are clinically proven, registered and trusted - specifically designed to reduce swelling and relieve various pain conditions - covering a wide variety of needs for adults, children and pets. Hand washable and mold resistant using a proprietary all-natural corn product as the heating and cooling element within the product line, Thermal-Aid stands alone in its category with consistent five-star reviews on Amazon Prime.

"Brian and his team at Linker & Associates are well positioned in the U.S. healthcare products market to identify and support exciting new commercial opportunities for Thermal-Aid," said Jennifer Mills, President of Med-X. "We believe Brian's extensive relationships in the consumer products industry, longstanding industry experience and robust sales capabilities will provide an immediate impact on the sales and distribution of Thermal-Aid products. Acting like an extension of our in-house sales team, Brian will provide additional reach into healthcare and pharmacy wholesalers which we believe will generate the most lucrative incremental sales opportunities for our shareholders, building upon what is already a record year for our family of brands."

Brian Linker added: "Med-X's Thermal-Aid product line brings incredible innovation to a long-tired category - acting not only as a hot and cold pack - but as an accessory with re-buy potential, turning a medical product into something adults and their children actually want to use. From initial reactions to samples I've seen, Med-X is onto something truly special with Thermal-Aid. I look forward to working closely with the Med-X team to introduce these incredible products to leading healthcare distributors nationally."

About Med-X, Inc.

Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit www.medx-rx.com.

Disclaimer and Forward-Looking Statements

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the Regulation A+ Offering Circular Securities and Exchange Commission filings before making any investment in the Company. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Investor Relations Contact

Lucas Zimmerman
Director
MZ Group - MZ North America
949-259-4987
MXRX@mzgroup.us
www.mzgroup.us

SOURCE: Med-X, Inc.



View source version on accesswire.com:
https://www.accesswire.com/714447/Med-X-Appoints-Linker-Associates-as-Sales-Representative-to-Spearhead-Business-Development-for-Thermal-Aid-Division

© 2022 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.